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THE objective of this study was to test the hypothesis
that an oxidative stress can serve as a signal to
regulate the expression of CCR5. When human
monocytes were exposed to graded concentration
of hydrogen peroxide (H2O2), CCR5 mRNA levels
increased maximally at 4 h of exposure to 200 mM
of H2O2 and decreased by 24 h of treatment. Pretreat-
ment of monocytes with the NF-kB inhibitor BAY 11-
8072 blocked the H2O2-induced augmentation of
CCR5 mRNA expression, suggesting a role for this
transcription factor in the regulation of CCR5 expres-
sion. CCR5 protein expression on the plasma mem-
brane was also increased by treatment with H2O2, as
assessed by flow cytometry. This was accompanied
by enhanced responsiveness of H2O2-pretreated
monocytes to the CCR5 ligand MIP-1b in terms of
chemotaxis and c-fos gene activation. Our results
suggest that oxidative stress may indeed modulate the
expression of chemokine receptors and thus contri-
bute to regulation of the inflammatory process.
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Introduction
Recruitment of inflammatory cells to a tissue site is a
complex process that depends in part on the local
expression of appropriate chemoattractant proteins
termed chemokines. The interaction of chemotactic
factors with their corresponding receptors on leuko-
cytes constitutes the basis for chemotaxis to inflam-
matory sites and cell activation. In addition to the
production of chemotactic factors, the level of
expression of their receptors on target cells will
determine the magnitude of the response. CCR5
is a G-protein-coupled receptor that binds the
chemokines monocyte inflammatory protein (MIP)-
1a, MIP-1b and RANTES.
1,2 CCR5 is expressed
on monocytes/macrophages, activated T cells and
dendritic cells in lymphoid tissues, the ovaries
and the lungs.
3 It has been proposed to be impli-
cated in several inflammatory diseases, such
as rheumatoid arthritis, asthma and glomerulo-
nephritis.
4 7
Inflammatory cells, such as macrophages and
neutrophils, play an important role in host defense,
but may also contribute to tissue injury through the
release of reactive oxygen species (ROS).
8 10 In-
creased production of ROS is now believed to be
implicated in the pathogenesis of inflammatory dis-
ease such as acute respiratory distress syndrome,
asthma, rheumatoid arthritis and AIDS.
11 14 In addi-
tion, ROS are recognized as mediators of cell
apoptosis.
15 19 The role of the second messenger in
signal transduction requires small, non-toxic concen-
trations of ROS that can be produced by every cell
type. ROS have been shown to affect the production
of the chemokine interleukin (IL)-8 in dendritic cells
and monocytes,
20,21 monocyte chemotactic protein
(MCP)-1 in monocytes and MIP-1a in the alveolar
macrophages cell line NR8383.
22 These effects may
be mediated in part through the action of ROS on
redox-sensitive proteins, such as the transcription
factor nuclear factor (NF)-kB,
23 29 or some upstream
protein kinases.
30 NF-kB regulates many of the genes
involved in the immune response, including IL-2, IL-
6, IL-8, interferon-g, tumour necrosis factor (TNF)-a,
vascular cell adhesion molecule-1 and intracelular
adhesion molecule-1.
31 It is a heterodimer of 50 kDa
(p50) and 65 kDa (p65) subunits and is found in the
cytoplasm in an inactive form, bound to the inhibi-
tory protein IkB through the p65 moiety.
32,33 In
response to various stimuli, including proinflamma-
tory cytokines, IkB-a is first phosphorylated by IKK
and then rapidly degraded by the proteasome,
allowing translocation of NF-kB to the nucleus and
subsequent gene activation.
34,35
The CCR5 gene promoter contains consensus
binding sequences for the transcriptional activating
factor NF-kB.
36 In this study, we investigated the
hypothesis that ROS can increase the expression of
the chemokine receptor CCR5 in human monocytes
and thus contribute in the inflammatory process. We
show here that hydrogen peroxide (H2O2), a cell
membrane-permeable ROS, can indeed upregulate
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29CCR5 expression in monocytes and increase their
responsiveness to the CCR5 ligand MIP-1b.
Materials and methods
Chemical reagents
H2O2 and dimethyl-sulfoxide were from Fisher
Scientific (Fair Lawn, NJ, USA). MIP-1b was obtained
from Pepro Tech (Rocky Hill, NJ, USA) and actino-
mycin D was from Merck Sharp & Dohme Interna-
tional (Rahway, NJ, USA). BAY 11-7082 was from
Calbiochem (San Diego, CA, USA) and catalase was
from Sigma-Aldrich Chemie (Steinheim, Germany).
Preparation of monocytes
Human venous blood from healthy medication-free
volunteers was collected on citrate/dextrose/ade-
nine. The peripheral blood mononuclear leukocytes
were enriched by dextran sedimentation, layered
over a Ficoll /Hypaque cushion and centrifuged at
400 /g for 20 min. Mononuclear leukocytes were
collected at the interface and washed twice with
phosphate-buffered saline (PBS) and resuspended in
RPMI 1640 medium with 10% heat-inactivated fetal
bovine serum (FBS). Monocytes were then purified
by adherence (60 min, 378C) to the surface of plastic
petri dishes coated with defibrinized autologous
serum and removed with ethylenediamine tetraacetic
acid (EDTA) (0.01 M) in RPMI 1640, 10% FBS. This
was effective in enriching the cell population to
greater than 90% monocytes, with a viability greater
than 98% as assessed by Wright /Giemsa staining and
trypan blue exclusion, respectively. Cells were re-
suspended in RPMI 1640, 10% FBS, at a final
concentration of 2 /10
6 cells/ml. Monocytes were
left to rest overnight in polypropylene tubes to allow
them to return to baseline status following initial
activation by adherence. The medium was then
removed by pipetting and replaced by fresh RPMI
1640 without FBS 1 h before stimulation with
hydrogen peroxide. The 30% H2O2 stock was diluted
in RPMI immediately before treatment. Cell viability
after treatment was measured by trypan blue exclu-
sion.
mRNA studies
After appropriate treatment, cells were pelleted in 15
ml polypropylene tubes and the total cellular RNA
was isolated by acid guanidium thiocyanate /
phenol /chloroform extraction according to Chomc-
zynski and Sacchi.
37 RNA (10 mg) was separated by
electrophoresis on 1% agarose and transferred onto a
Hybond-N (Amersham, Arlington Heights, IL, USA)
membrane for northern analysis. The cDNA corre-
sponding to the whole coding sequence of human
CCR5 was obtained as previously described
38 from
genomic DNA of Raji cells using the primers 5?-
GCTCTAGAGATTATCAAGTGTC-3? (sense), and 5?-
GGGGTACCTCACAAGCCCACAGATATTTCCTGCTC-
CCC-3? (antisense). The c-fos cDNA probe was
obtained from the American Type Culture Collection
(Rockville, MD, USA). Control hybridizations were
performed with the human glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) cDNA probe ob-
tained from the American Type Culture Collection.
The probes were labelled with a multiprime DNA
labeling system (Amersham) using [
32P]dCTP (speci-
fic activity  /3000 Ci/mmol; Amersham). Membranes
were prehybridized for 4 h in a mixture containing
120 mM of Tris, 600 mM of NaCl, 8 mM of EDTA, 0.1%
sodium pyrophosphate, 0.2% sodium dodecyl sul-
phate, and 100 mg/ml of heparin. Hybridization was
performed overnight at 688C in the same mixture in
which the concentration of heparin was increased to
625 mg/ml and dextran sulfate at 10% was added. The
membranes were then washed once at room tem-
perature for 20 min in 2 /SSC (1 /SSC: 0.15 M of
NaCl, 0.15 M of sodium citrate, pH 7); once with 0.1 x
SSC, 0.1% sodium dodecyl sulphate at 688Cf o r6 0
min, and then rinsed at room temperature with 0.1 /
SSC. The membranes were exposed to Kodak XAR-5
film (Eastman Kodak, Rochester, NY, USA) with
intensifying screens for 24 h at   /808C. Signal
intensity was quantitated by densitometry using a
UMAX PowerLook II scanner with the UMAX Magic
Scan DA3.1 software and analysed with the NIH
Image 1.61 software (Bethesda, MD, USA) on a
Macintosh 7300/200 computer. Densitometric values
are expressed as ratios of receptor/GAPDH or
receptor/28s RNA densitometry quantification and
normalized for control /1.
Flow cytometry
The expression of CCR5 on the surface of monocytes
was assessed with the monoclonal anti-CCR5 anti-
body (2D7) (PharMingen, Mississauga, Ontario, Ca-
nada) and anti-IgG2a antibody (PharMingen) at 2.5
mg/ml, as previously described.
38 In brief, 3 /10
5
treated cells were washed twice with PBS and
labelled for 30 min at 48C with anti-CCR5, washed
with cold PBS and incubated for 30 min at 48C with
FITC-conjugated goat anti-mouse IgG (Bio/Can
Scientific, Mississauga, Ontario, Canada). Finally,
cells were washed and resuspended in PBS before
flow cytometry analysis with a FACScan flow cyt-
ometer (Becton-Dickinson, San Jose, CA, USA).
Results are expressed as the mean peak channel
fluorescence for each treatment.
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Monocyte chemotactic activity was performed in
modified single-well Boyden chambers separated
by 5 mm pore size polycarbonate filters (Neuroprobe,
Cabin John, MD, USA), as previously described.
38
MIP-1b or medium was added to the lower chamber
and 200 ml of monocytes (6 /10
5) in Gey’s BSS
(Gibco-BRL, Burlington, ON, Canada), supplemented
with 2% bovine serum albumin, were added to the
upper chamber. In chemokinesis assays, both cham-
bers contained an equal concentration of MIP-1b.
After incubation for 2 h at 378C, the filters were
disassembled and the upper side of the filters were
scraped free of cells. Cells on the lower side were
removed with 5 mM of EDTA, centrifuged and
counted.
Statistical analysis
Data were analysed for statistical significance using
analysis of variance or Student’s t-test for paired
values, as appropriate. Differences were considered
significant at p B/0.05. Results are expressed, when
relevant, as means9 /SEM.
Results
Monocytes isolated from different blood donors were
treated with graded concentrations of H2O2 for 4 h
and mRNA levels encoding CCR5 were measured by
northern blot analysis. As illustrated in Fig. 1, H2O2
induced a concentration-dependent augmentation of
CCR5 mRNA expression in human monocytes with a
maximum induction at 200 mMo fH 2O2. Parallel
experiments were performed to evaluate the effect of
H2O2 on the expression of the chemokine receptor
CXCR4 and the receptor for the lipid mediator,
platelet-activating factor (PAFR). As illustrated in
Fig. 2A, H2O2 also induced an increase in CXCR4
mRNA expression, albeit of a lesser magnitude, but
had no effect on PAFR mRNA expression (Fig. 2B). In
a time-course study, illustrated in Fig. 3, the effect of
H2O2 on CCR5 mRNA levels was detectable as early
as at 2 h of treatment, was maximal by 4 h and
decreased by 24 h.
Increased mRNA expression is commonly con-
trolled by a transcriptional or post-transcriptional
mechanism. To determine whether H2O2 elevated
CCR5 mRNA levels through transcriptional activation,
monocytes were pretreated with Actinomycin D, a
transcriptional inhibitor, for 15 min. The cells were
then treated with medium or 200 mMo fH 2O2 for 3 h.
Total cellular RNA was then extracted and northern
blot analysis was performed. As illustrated in Fig. 4,
this treatment blocked the H2O2-induced accumula-
tion of CCR5 mRNA, suggesting that H2O2-regulated
CCR5 expression involves a transcriptional mechan-
ism.
Since the transcription factor NF-kB has been
shown to be affected by H2O2 in some cell lines
and in T lymphocytes,
29,39 and because the CCR5
gene promoter contains consensus binding se-
quences for this transcription factor,
36 we examined
FIG. 1. Induction of CCR5 mRNA expression by H2O2 in
human monocytes. Human monocytes were incubated for 4
h with graded concentrations of H2O2 in serum-free RPMI
1640 medium and total RNA was extracted and analysed by
northern blotting for CCR5 mRNA expression. (A) Autoradio-
gram of one representative experiment. (B) Densitometric
quantiﬁcation of CCR5 mRNA normalized to GAPDH mRNA.
The results represent the means9 /SEM of nine independent
experiments. * pB/0.05, H2O2-treated versus control cells.
FIG. 2. Effect of H2O2 on the expression of CXCR4 and PAFR
mRNA in human monocytes. Human monocytes were
incubated for 4 h with graded concentrations of H2O2 in
serum-free RPMI 1640 medium and total RNA was extracted
and analysed by northern blotting for CXCR4 and PAFR
mRNA expression. (A) Autoradiogram of northern blot
hybridized with radiolabelled CXCR4 cDNA. The same
membrane was rehybridized with radiolabelled PAFR (B) or
GAPDH (C) cDNA.
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expression of CCR5 mRNA. As shown in Fig. 5, CCR5
mRNA induction by H2O2 was largely inhibited
following pretreatment with 20 mM of BAY 11-7082,
an inhibitor of IkB-a phosphorylation. Thus, the
stimulatory effects of H2O2 on CCR5 expression
appears to be mediated, at least in part, through the
activation of the NF-kB signalling pathway.
We then investigated whether H2O2-induced accu-
mulation of CCR5 mRNA was associated with an
increased expression of CCR5 protein on the cell
surface. Monocytes were treated for 4 h with either
medium or 200 mMH 2O2. Supernatants were then
replaced with new medium and cells were incubated
for 16 h. Flow cytometry studies were then per-
formed using the 2D7 monoclonal anti-CCR5 anti-
body. As illustrated in Fig. 6, H2O2 treatment of
monocytes induced a marked increase in membrane
expression of CCR5, as compared with untreated cells
(H2O2-treated monocytes, 6.119 /1.7 peak channel
fluorescence versus control cells, 2.449 /0.6; pB/
0.05).
To assess the specificity of action of H2O2, mono-
cytes were treated with H2O2 in the presence or
absence of catalase, which degrades H2O2 to H2O
and O2. As expected, the H2O2-induced upregulation
of CCR5 expression was prevented by catalase both
at the mRNA and protein levels (Fig. 7A,B). Interest-
ingly, however, catalase itself was found to increase
the expression of CCR5.
We next investigated whether the H2O2-induced
upregulation of CCR5 expression was associated with
augmented responsiveness of treated monocytes to
the CCR5 ligand MIP-1b. Receptor function was first
evaluated for MIP-1b-induced chemotaxis; as shown
in Fig. 8, monocytes pretreated with H2O2 showed
enhanced responsiveness to the chemotactic action
of MIP-1b. Chemokinetic activity in response to MIP-
1b was not affected, however (data not shown).
CCR5 function was also evaluated in terms of MIP-1b-
induced c-fos expression. After a 4 h pretreatment
with 200 mMo fH 2O2, followed by an incubation of
16 h in new medium, cells were treated for 30 min
with 50 or 100 ng/ml of MIP-1b and the total RNA was
FIG. 3. Time course of H2O2-induced upregulation of CCR5
gene expression. Monocytes were incubated in the absence
or presence of H2O2 (200 mM) for the indicated time periods
followed by northern blot analysis of CCR5 gene expression.
Total RNA was then extracted and analysed by northern blot
for CCR5 and GAPDH gene expression. The results are
representative of two independent experiments.
FIG. 4. Effect of Actinomycin D (Act-D) on CCR5 mRNA
expression in response to H2O2. Monocytes were incubated
in the absence or presence of Actinomycin D (10 mg/ml) for
15 min before addition of either medium or H2O2 for 3 h.
Total RNA was then extracted and analysed by northern blot
for CCR5 and GAPDH gene expression. The results are
representative of two independent experiments.
FIG. 5. Effect of BAY 11-7082 pretreatment on H2O2-induced
CCR5 mRNA expression. Monocytes were incubated in the
absence or presence of Bay 11-7082 (20 mM) for 30 min
before addition of either medium or H2O2 (200 mM). Total
RNA was extracted and analysed by northern blot for the
expression of CCR5 and GAPDH mRNA. The results are
representative of three independent experiments.
FIG. 6. Effect of H2O2 on CCR5 protein expression. Mono-
cytes were treated with 200mMo fH 2O2 for 4 h in serum-free
medium and centrifuged for 5 min at 1000 rpm. The medium
was then replaced by new medium and the cells were
incubated for 16 h. The medium was then removed by
aspiration without centrifugation. Cells were labelled with
either an irrelevant antibody (shaded) or anti-CCR-5 (2D7)
antibody, followed by FITC-conjugated goat anti-mouse
antibody. Cells were analysed by ﬂow cytometry (untreated
cells, thin line; H2O2-treated cells, thick line). A representative
experiment of nine independent experiments is illustrated.
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Fig. 9, c-fos mRNA expression was markedly in-
creased in H2O2-pretreated monocytes following
exposure with MIP-1b, compared with untreated
cells. These observations suggest that the increased
expression of CCR5 following H2O2 treatment is
associated with enhanced functional activities of the
receptor.
Discussion
It is now accepted that a wide variety of cell types can
respond to oxidative stress by the induction of
multiples genes controlled by redox-sensitive pro-
teins.
40 Several investigators have demonstrated that





role for ROS in the inflammation process. In this
report, we demonstrated that externally applied
H2O2, a cell-permeable oxidant, significantly in-
creased mRNA expression of the chemokine recep-
tors CCR5 and, to a lesser extent, CXCR4 in human
monocytes. Similar findings were recently reported
by Saccani et al.,
43 who also found that the antiox-
idant pyrrolidinedithiocarbamate (PDTC) downregu-
lated the expression of CCR5 and CXCR4.
FIG. 7. Effect of catalase on CCR5 expression. (A) Monocytes
were treated with 200 mMo fH 2O2 in the absence or presence
of catalase (400 U/ml) for 4 h in serum-free medium and total
RNA was extracted and analysed by northern blotting for
CCR5 mRNA expression. Autoradiogram of one representa-
tive experiment. (B) Monocytes were treated with 200 mMo f
H2O2 in the absence or presence of catalase (400 U/ml) for 4 h
in serum-free medium. The medium was then replaced
following centrifugation by new medium and the cells were
incubated for 16 h at 378C. The medium was then removed
by aspiration without centrifugation. Cells were labelled with
either an irrelevant antibody (shaded) or anti-CCR-5 (2D7)
antibody, followed by FITC-conjugated goat anti-mouse
antibody. Cells were analysed by ﬂow cytometry (untreated
cells, thin line; H2O2-treated cells, thick line).
FIG. 8. Effect of H2O2 on monocyte chemotaxis. Monocytes
were treated with either medium or 200 mMo fH 2O2 for 4 h in
serum-free medium. The medium was then replaced by new
medium and the cells were incubated for 16 h at 378C.
Chemotactic activity was measured in response to MIP-1b
using a modiﬁed Boyden chamber chemotaxis assay. The
ﬁgure illustrates the means9 /SEM of triplicate determina-
tions of one representative experiment.
FIG. 9. Effect of H2O2 on MIP-1b-induced c-fos expression.
Monocytes were treated with either medium or 200 mMo f
H2O2 for 4 h in serum-free medium. The medium was then
replaced by new medium and the cells were incubated for 16
ha t3 7 8C. MIP-1b or medium were then added for 20 min and
total RNA was extracted for northern blot analysis. The
autoradiogram of one experiment representative of two
independent experiments is shown.
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the upregulation of CCR5 by H2O2 was dependent on
transcriptional activity and could be prevented by
inhibition of NF-kB activation. Moreover, the H2O2-
induced augmentation of CCR5 mRNA levels was
associated with enhanced CCR5 expression at the cell
surface. We further demonstrated that these newly
induced receptors were functional since pretreatment
with H2O2 was associated with an augmented re-
sponsiveness of monocytes to MIP-1b in terms of cell
migration as well as c-fos gene activation.
The transcription factor NF-kB is involved in the
expression of a wide variety of genes controlling
immune and inflammatory responses. Several lines of
evidence suggest a role for ROS as a common and
critical intermediate in NF-kB activating signals. For
example, the antioxidant PDTC or the overexpres-
sion of superoxide dismutase have been shown to be
inhibitory for TNF-induced activation of NF-kBi n
Jurkat T cells.
27,44 47 It has also been shown that
addition of H2O2 to specific cell types results in the
appearance of the phosphorylated form of IkB-a,
whereas treatment with reducing agents such as
dithiothreitol and b-mercaptoethanol enhances
DNA-binding activity of NF-kB itself.
48 Consistant
with these reports, treatment with antioxidants or
overexpression of antioxidant enzymes can block
IkB-a phosphorylation and degradation induced by
lipopolysaccharide, TNF-a and phorbol-myristate
acetate (PMA).
35 These observations suggest that
redox regulation may affect more than one step in
the NF-kB activating pathway. Although the molecu-
lar mechanism of the redox regulation of NF-kBi s
still unclear, signalling molecules such as protein
kinases, which are involved in the dissociation of IkB
from the NF-kB complex, may be targets of the redox
regulation. Our study also suggests a role for the NF-
kB pathway in the effect mediated by H2O2 on CCR5
expression in monocytes. Since the preatreatment of
cells with an IkB-a phosphorylation inhibitor resulted
in a partial inhibition of the H2O2-mediated induction
of CCR5 mRNA, we can suppose that IkB-a itself or
some upstream factors, such as one or more protein
kinases, could be the target for the oxidant. More-
over, the CCR5 gene promoter also contains con-
sensus binding sequences for the transcriptional
activating factor AP-1 and for such regulatory ele-
ments as STAT,
36 which have recently been shown to
be redox sensitive.
30 These findings present the
possibility that additional transcription factors might
be implicated in the regulation of CCR5 expression
by H2O2.
Regulation of chemokine receptors by reactive
oxygen species may be important in the pathogenesis
of several inflammatory diseases. ROS have been
shown to be produced by immune cells after activa-
tion by proinflammatory cytokines, such as IL-1 and
TNF-a.
49 ROS are also implicated in a number of
inflammatory diseases where expression of CCR5
ligands is enhanced, such as in rheumatoid arthritis,
sepsis and autoimmune encephalomyelitis.
50 53 Un-
derstanding the effect of ROS in the direct environ-
ment of inflammatory cells could lead to a better
understanding of the mechanisms implicated in the
progression of these diseases.
In conclusion, our results demonstrate that ROS in
the extracellular environment of human monocytes
can increase the expression of the chemokine
receptor CCR5 through redox-sensitive transcription
factors, such as NF-kB. In an inflammatory disease
context, activated phagocytic cells would release
inflammatory mediators and ROS, such as H2O2.
H2O2 accumulation in the environment of immune
cells would then promote an increase in CCR5
expression on the cell surface of monocytes, leading
to a greater response to the chemokines MIP-1a, MIP-
1b and RANTES. This increased response to chemo-
kines would extend the inflammatory process and
possibly facilitate a greater accumulation of activated
monocytes at the inflammatory site.
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